Market Research Logo

Global Blood Plasma Market: Trends, Opportunities and Forecasts (2015-2020) - (By Market Segment, Type of Blood Plasma -IVIG, Albumin, Factor VIII, By Region-North America, Europe, APAC, Market Entry Strategies for Global Players)

Global Blood Plasma Market: Trends, Opportunities and Forecasts (2015-2020) - (By Market Segment, Type of Blood Plasma -IVIG, Albumin, Factor VIII, By Region-North America, Europe, APAC, Market Entry Strategies for Global Players)

Executive Summary

The market is driven by the consumer awareness of health care resulting in access for treatment along with increase in the global ageing populace which faces these kind of health problems at that age. Global Blood Plasma Market is a growing market with key players holding dominant positions and is classified on the basis of drugs market. Global Blood Plasma Market has been growing at an average pace over the last five years on account of growing number of old people and the demand in the different regions .During 2015-20, Global Blood Plasma Market is anticipated to grow at an increased rate on account of the rapid increase of the healthcare expenditure on the diseases related to the blood plasma i.e. immunodeficiency, clotting disabilities etc.. The plasma market is still on the growing end at a CAGR of 10.54% where major players are having strong presence in market, considering more number of patients being treated for these diseases. The growth in ageing population, rise in healthcare expenditure and R&D of the new products also create a demand for the products making the market to grow at a steady pace.According to Azoth Analytics research report, Global Blood Plasma Market: Trends, Opportunities and Forecasts (2015-2020) - (By Market Segment, Type of Blood Plasma -IVIG, Albumin, Factor VIII, By Region-North America, Europe, APAC, Market Entry Strategies for Global Players), global blood plasma market is projected to exhibit a CAGR of 10.54% during 2015 - 2020. Few of the leading companies operating in blood plasma market in world include CSL Behring, Baxter, Grifols SA and Octapharma, etc.

Scope of the Report

“Global Blood Plasma Market: Trends, Opportunities and Forecasts (2015-2020) - (By Market Segment, Type of Blood Plasma -IVIG, Albumin, Factor VIII, By Region-North America, Europe, APAC, Market Entry Strategies for Global Players)” analyses the following aspects of Global Blood Plasma Market:

  • Analysis of Key Market Segments - IVIG, Albumin, Factor VIII
  • Analysis of Key Market Segments - IVIG, Albumin, Factor VIII BY Geography – North America, Europe, APAC
  • Executive Summary – Market, Drivers & Challenges and Trends.
  • Global Blood Plasma Market, Size & Forecast.
Why You Should Buy This Report?
  • To gain an in-depth understanding of Global Blood Plasma Market
  • To identify the on-going trends and anticipated growth in the next five years
  • To help industry consultants, blood plasma manufacturers, suppliers and distributors align their market-centric strategies
  • To gain insights on the prevalent market entry strategies in blood plasma market for domestic as well as foreign companies
  • To obtain research based business decision and add weight to presentations and marketing material
  • To gain competitive knowledge of leading players
  • To avail limited customization in the report without any extra charges and get research data or trends added in the report as per the buyer’s specific needs


1. Research Methodology
2. Product Overview
3. Executive Summary
4. Global Blood Plasma Market: An Analysis
4.1. Global Blood Plasma Market: Size, Growth and Forecast
4.1.1. By Value & Forecast
Table 1: Global Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
Table 2: Growth in Global Ageing Population (2010-2014) in Million
Table 3: Global Blood Plasma Market Size, By Value, 2015E-2020F (USD Billion)
Table 4: Global Per Capita Health care Expenditure (USD)
4.2. Global Blood Plasma Market: Segment Shares & Analysis
4.2.1. By Product Type
Table 5: Blood plasma Market Share, By Product 2014
Table 6: Blood Plasma Market Share, By Product, By Value, 2014(USD Billion)
4.2.2. By Company
Table 7: Blood plasma Market, By Company Share 2014 (Percentage)
Table 8: Blood Plasma Market, Company Share, By Value, 2014(USD Billion)
Table 9: Blood plasma Market Immunoglobulin By Company 2014
Table 10: Blood plasma Market Factor VIII By Company 2014
4.3. Global Albumin Type Blood Plasma Market: Size, Growth and Forecast
4.3.1. By Volume
Table 11: Global Albumin Market Size, By Volume, 2010-2014 (tons)
Table 12: Global Albumin Market Size, By Volume, 2015E-2020E (tons)
4.3.2. By Value
Table 13: Global Albumin Market Size, By Value, 2010-2014 (USD Billion)
Table 14: Global Albumin Market Size, By Value, 2015E-2020E (USD Billion)
4.3.3 By Company
Table 15: Blood plasma Market Albumin By Company 2014
4.4. Global IVIG Type Blood Plasma Market: Size, Growth and Forecast
4.4.1. By Volume
Table 16: Global IVIG Market Size, By Volume, 2010-2014 (tons)
Table 17: Global IVIG Market Size, By Volume, 2015E-2020E (tons)
4.4.2 By Value
Table 18: Global IVIG Market Size, By Value, 2010-2014 (USD Billion)
Table 19: Global IVIG Market Size, By Value, 2015E-2020E (USD Billion)
4.5. Global Factor VIII Type Blood Plasma Market: Size, Growth and Forecast
4.5.1 Overview
4.5.2 By Value
Table 20: Global Factor VIII Market Size, By Value, 2010-2014 (USD Billion)
Table 21: Global Factor VIII Market Size, By Value, 2015E-2020E (USD Billion)
4.5.3 By Volume
Table 22: Global Factor VIII Market Size, By Volume, 2010-2014 (International Units)
Table 23: Global Factor VIII Market Size, By Volume, 2015E-2020E (International Units)
4.6. Other Blood Products Market: Size, Growth and Forecast
4.6.1. By Value (Forecast 2020F)
Table 24: Other Blood Products Market Size, By Value, 2010-2014 (USD Billion)
Table 25: Other Blood Products Market Size, By Value, 2015E-2020E (USD Billion)
5. North America Blood Plasma Market: Size, Growth and Forecast
5.1. Overview
5.2. By Value (Forecast 2015E-2020F)
Table 26: North America Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
Table 27: North America Blood Plasma Market Size, By Value, 2015E-2020E (USD Billion)
5.3. Factors Affecting Market
Table 28: North America Aging Population, 2010-2020 (Million)
Table 29: North America Blood Plasma Export to China, By Value, 2010-2014 (USD Billion)
Table 30: Plasma Collection In America, By Volume, 2010-2014 (Million Litres)
6. APAC Blood Plasma Market: Size, Growth and Forecast
6.1. Overview
6.2. By Value (Forecast 2015E-2020F)
Table 31: APAC Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
Table 32: APAC Blood Plasma Market Size, By Value, 2015E-2020E (USD Billion)
6.3. Factors Affecting Market
Table 33: China Blood Plasma Import from North America, By Value, 2010-2014 (USD Million)
7. Europe Blood Plasma Market: Size, Growth and Forecast
7.1. By Value (Forecast 2015E-2020F)
Table 34: Europe Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
Table 35: Europe Blood Plasma Market Size, By Value, 2015E-2020E (USD Billion)
8. RoW Blood Plasma Market: Size, Growth and Forecast
8.1. Overview
8.2. By Value (Forecast 2015E-2020F)
Table 36: ROW Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
Table 37: ROW Blood Plasma Market Size, By Value, 2015E-2020E (USD Billion)
8.3. Factors Affecting Market
9. Blood Plasma Market Trends
9.1. Overview
9.1.1. Solid and Stable Pricing Power in IG Market
9.1.2. Fast Growth of SCIG Market
9.1.3. Industrial Fractionators Planning Capacity Expansion
9.1.4. Increase in Albumin Market in China
9.1.5. Immunoglobulin Segment- High Profitability and Strength
Table 38: IVIG (KG/M) Usage Comparison
10. Global Blood Plasma Market Dynamics
10.1. Growth Drivers
10.1.1. Augmentation in Plasma accumulations in the US
Table 39: US Plasma Accumulations (2010-2014)
10.1.2. Rise in Global Healthcare Expenditure
Table 40: Rise in Global Healthcare Expenditure, 2010-2014 USD
10.1.3. Growth in Ageing Population
Table 41: Growth in Global Ageing Population (2010-2014) Million
10.1.4. Growth in Male Population
Table 42: Growth in Male Population, 2010-2014 (Million)
10.1.5. Development Potential from New Indications
10.2. Challenges
10.2.1. Rivalry from Recombinant Factor VIII
10.2.2. Prospective Threat to Immunoglobulin Market
10.2.3. Costing Pressure in Tenders in Plasma-Derived FVIII Market
10.2.4. High Manufacturing and Safety Cost
11. Blood Plasma Market: Policy and Regulatory Landscape
11.1. WHO Blood Safety Regulations
11.2. FDA Blood Safety Regulations
11.3. CANADA CAN/CSA-Z902-10 (R2015) - Blood and blood components
11.4. PHARMACEUTICAL AND FOOD SAFETY BUREAU (PFSB) JAPAN
11.5. UK Blood Safety Regulations
11.6. Australia Blood Safety Regulations
11.7. India Plasma Product Safety Regulations
12. Blood Plasma Market: Value Chain Analysis
12.1. Supply Chain Diagram
12.2. BLOOD PLASMA SUPPLY CHAIN
13. Blood Plasma Trade Data Analysis
13.1. Top 5 Nations with Import By Volume (Million KGS)
Table 43: Blood Plasma Imports, By Top Countries, 2010-2014 (Million KGS)
13.2. Top 5 Nations with Export By Volume (Million KGS)
Table 44: Blood Plasma Exports, By Top Countries, 2010-2014 (Million KGS)
13.3. Top 5 Nations with Import by Value (Billion $)
Table 45: Blood Plasma Imports, By Top Countries, 2010-2014 (Billion $)
13.4. Top 5 Nations with Export by Value (Billion $)
Table 46: Blood Plasma Exports, By Top Countries, 2010-2014 (Billion $)
14. Blood Plasma Market: Porter’s Five Force Analysis
14.1. Porter Five Force Model Blood Plasma
15. Blood Plasma Market: Competitive landscape
15.1. Blood Plasma Market: Company Financials
15.1.1. Top 5 Companies Sales
Table 47: Top 5 Companies Sales in USD Billion
15.1.2. Bottom 5 Companies Sales
Table 48: Bottom 5 Companies Sales in USD Million
15.1.3. Top 5 Companies EBITDA
Table 49: Top 5 Companies EBITDA in USD Billion
15.1.4. Bottom 5 Companies EBITDA
Table 50: Bottom 5 Companies EBITDA in USD Billion
15.1.5. Top 5 Companies EBIT
Table 51: Top 5 Companies EBIT in USD Billion
15.1.6. Bottom 5 Companies EBIT
Table 52: Bottom 5 Companies EBIT in USD Billion
15.1.7. Top 5 Companies PBT
Table 53: Top 5 Companies PBT in USD Billion
15.1.8. Bottom 5 Companies PBT
Table 54: Bottom 5 Companies PBT in USD Billion
15.1.9. Top 5 Companies PAT
Table 55: Top 5 Companies PAT in USD Billion
15.1.10. Bottom 5 Companies PAT
Table 56: Bottom 5 Companies PAT in USD Billion
15.2 Company Ratios
15.2.1. Top 5 Companies Current Ratio
Table 57: Top 5 Companies Current Ratio
15.2.2. Bottom 5 Companies Current Ratio
Table 58: Bottom 5 Companies Current Ratio
15.2.3. Top 5 Companies Profit Margin
Table 59: Top 5 Companies Profit Margin
15.2.4. Bottom 5 Companies Profit Margin
Table 60: Bottom 5 Companies Profit Margin
15.2.5. Top 5 Companies Debt Equity Ratio
Table 61: Top 5 Companies Debt Equity Ratio
16. Global Blood Plasma Market: Company Profiles
16.1. CSL Ltd.
Table 62: CSL Ltd. Percentage Revenue, By Product Segment (2014-2015)
Table 63: CSL Ltd. Percentage Revenue, By Geography (2014-2015)
Table 64: CSL Ltd. Sales (USD Billion) 2010-2014
16.2 Baxter International Inc
Table 65: Baxter International Inc. Percentage Revenue, By Product Segment (2014)
Table 66: Baxter International Inc. Percentage Revenue, By Geography (2014)
Table 67: Baxter International Inc. Sales (USD Billion) 2010-2014
16.3 Grifols S.A
Table 68: Grifols S.A Percentage Revenue, By Product Segment (2014)
Table 69: Grifols S.A Percentage Revenue, By Geography (2014)
Table 70: Grifols SA Sales (USD Billion) 2010-2014
16.4 Antares Pharma Inc
Table 71: Antares Pharma Inc. Revenue (USD Billion) 2010-2014
16.5 Emergent BioSolutions, Inc.
Table 72: Emergent BioSolutions, Inc. Revenue (USD Billion) 2010-2014
16.6 AMAG Pharmaceuticals, Inc.
Table 73: AMAG Pharmaceuticals, Inc. Revenue (USD Billion) 2010-2014
16.7 Cipla
16.8 Octopharma
Table 74: Octopharma Revenue (USD Billion) 2010-2014
16.9 Biota Pharmaceuticals, Inc.
Table 75: Biota Pharmaceuticals, Inc. Revenue (USD Billion) 2010-2014
16.10 BioDelivery Sciences International, Inc.
Table 76: BioDelivery Sciences International, Inc. Revenue (USD Billion) 2010-2014
16.11 Flamel Technologies
Table 77: Flamel Technologies SA. Revenue (USD Billion) 2010-2014
17. Strategic Recommendations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report